United Therapeutics Corporation shares owned by Globeflex Capital
Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Globeflex Capital
from 13F filings
Historical chart of Globeflex Capital investment in United Therapeutics Corporation
Tip: Access up to 7 years of quarterly data
All positions including United Therapeutics Corporation held by Globeflex Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in United Therapeutics Corporation by Globeflex Capital
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $22M | 60k | 358.35 |
2024-06-30 | $19M | 61k | 318.55 |
2024-03-31 | $14M | 59k | 229.72 |
2023-12-31 | $13M | 59k | 219.89 |
2023-09-30 | $13M | 58k | 225.87 |
2023-06-30 | $12M | 55k | 220.75 |
2023-03-31 | $12M | 56k | 223.96 |
2022-12-31 | $14M | 52k | 278.09 |
2022-09-30 | $7.0M | 33k | 209.38 |
2022-06-30 | $1.6M | 6.9k | 235.61 |
2022-03-31 | $1.4M | 7.9k | 179.37 |
2021-12-31 | $1.7M | 7.9k | 216.11 |
2021-09-30 | $1.5M | 8.0k | 184.63 |
2021-06-30 | $1.4M | 8.0k | 179.37 |
2021-03-31 | $1.3M | 8.0k | 167.23 |
2020-12-31 | $1.2M | 8.2k | 151.84 |
2020-09-30 | $838k | 8.3k | 100.96 |
2020-06-30 | $1.5M | 12k | 121.02 |
2020-03-31 | $2.0k | 23 | 86.96 |
2019-03-31 | $158k | 1.3k | 117.30 |
2018-12-31 | $163k | 1.5k | 108.67 |
2018-09-30 | $192k | 1.5k | 128.00 |
2017-06-30 | $1.7M | 13k | 129.69 |
2017-03-31 | $1.5M | 11k | 135.35 |
2016-12-31 | $1.7M | 12k | 143.39 |
2016-09-30 | $1.4M | 12k | 118.09 |
2016-06-30 | $1.4M | 14k | 105.93 |
2016-03-31 | $1.5M | 14k | 111.43 |
2015-12-31 | $2.1M | 13k | 156.61 |
2015-03-31 | $3.0M | 17k | 172.43 |
2014-12-31 | $2.6M | 20k | 129.50 |
2014-09-30 | $5.8M | 45k | 128.65 |
2014-06-30 | $4.0M | 45k | 88.49 |
2014-03-31 | $1.1M | 12k | 94.02 |
2013-12-31 | $1.3M | 12k | 113.07 |
2013-09-30 | $6.2M | 79k | 78.85 |
2013-06-30 | $5.3M | 80k | 65.82 |
Top funds holding United Therapeutics Corporation
View all funds holding United Therapeutics Corporation